116 related articles for article (PubMed ID: 30905450)
1. Serum AFP levels in patients suffering from 47 different types of cancers and noncancer diseases.
He Y; Lu H; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():199-212. PubMed ID: 30905450
[TBL] [Abstract][Full Text] [Related]
2. Serum CA153 as biomarker for cancer and noncancer diseases.
Li X; Xu Y; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():265-276. PubMed ID: 30905456
[TBL] [Abstract][Full Text] [Related]
3. Serum CEA levels in 49 different types of cancer and noncancer diseases.
Hao C; Zhang G; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():213-227. PubMed ID: 30905451
[TBL] [Abstract][Full Text] [Related]
4. The serum SA levels are significantly increased in sepsis but decreased in cirrhosis.
Huang X; Yao Q; Zhang L; Tian Z
Prog Mol Biol Transl Sci; 2019; 162():335-348. PubMed ID: 30905461
[TBL] [Abstract][Full Text] [Related]
5. Serum CA50 levels in patients with cancers and other diseases.
Shan M; Tian Q; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():187-198. PubMed ID: 30905449
[TBL] [Abstract][Full Text] [Related]
6. Serum CA125 levels are decreased in rectal cancer but increased in fibrosis-associated diseases and in most types of cancers.
Zhang M; Zhang Y; Fu J; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():241-252. PubMed ID: 30905453
[TBL] [Abstract][Full Text] [Related]
7. Retrospective analysis of glycan-related biomarkers based on clinical laboratory data in two medical centers during the past 6 years.
Zhang M; Dou H; Yang D; Shan M; Li X; Hao C; Zhang Y; Zeng P; He Y; Liu Y; Fu J; Wang W; Hu M; Li H; Tian Q; Lei S; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():141-163. PubMed ID: 30905446
[TBL] [Abstract][Full Text] [Related]
8. [Evaluation of alpha-fetoprotein concentration in patients with chronic liver diseases].
Wójtowicz-Chomicz K; Cichoz-Lach H; Lis E; Kowalik A; Słomka M
Pol Merkur Lekarski; 2012 Jun; 32(192):374-7. PubMed ID: 22891562
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathologic features of gastric cancers producing alpha-fetoprotein.
Kono K; Amemiya H; Sekikawa T; Iizuka H; Takahashi A; Fujii H; Matsumoto Y
Dig Surg; 2002; 19(5):359-65; discussion 365. PubMed ID: 12435906
[TBL] [Abstract][Full Text] [Related]
10. Serum SCCA levels in patients suffering cancers or other diseases.
Yang D; Wang J; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():165-175. PubMed ID: 30905447
[TBL] [Abstract][Full Text] [Related]
11. Assessment of the correlation between serum prolidase and alpha-fetoprotein levels in patients with hepatocellular carcinoma.
Ilikhan SU; Bilici M; Sahin H; Akca AS; Can M; Oz II; Guven B; Buyukuysal MC; Ustundag Y
World J Gastroenterol; 2015 Jun; 21(22):6999-7007. PubMed ID: 26078578
[TBL] [Abstract][Full Text] [Related]
12. Prognostic significance of three hepatitis markers (p53 antibodies, vascular endothelial growth factors and alpha fetoprotein) in patients with hepatocellular carcinoma.
Gadelhak NA; Gadelhak SA; El-Morsi DA; Abdelaziz MM; Abbas AT; El-Emshaty HM
Hepatogastroenterology; 2009; 56(94-95):1417-24. PubMed ID: 19950803
[TBL] [Abstract][Full Text] [Related]
13. Serum CA199 levels are significantly increased in patients suffering from liver, lung, and other diseases.
Zeng P; Li H; Chen Y; Pei H; Zhang L
Prog Mol Biol Transl Sci; 2019; 162():253-264. PubMed ID: 30905455
[TBL] [Abstract][Full Text] [Related]
14. [Diagnostic value of serum alpha-fetoprotein, alpha-fetoprotein variant and abnormal prothrombin in primary hepatocellular carcinoma].
Hu RZ; Zhao SQ; Shen B; Guo GB
Zhonghua Gan Zang Bing Za Zhi; 2019 Aug; 27(8):634-637. PubMed ID: 31594082
[No Abstract] [Full Text] [Related]
15. Comparison of AFP-L3 and p53 Antigen Concentration with Alpha-Fetoprotein as Serum Markers for Hepatocellular Carcinoma.
Abdel-Aziz MM; Elshal MF; Abass AT; El-Kafrawy S; Ezzat S; Abdel-Wahab M
Clin Lab; 2016; 62(6):1121-9. PubMed ID: 27468575
[TBL] [Abstract][Full Text] [Related]
16. [Significance of serum alpha-fetoprotein determination. Experiences with our own radioimmunoassay].
Lamerz R; Schmalhorst U; Grunst J; Fateh-Moghadam A; Eisenburg J
Fortschr Med; 1976 Apr; 94(12):702-10. PubMed ID: 61154
[TBL] [Abstract][Full Text] [Related]
17. Alpha-fetoprotein producing tumor cells in children with Wilms' tumor.
Kesik V; Ozcan A; Sari E; Guven A; Kismet E; Koseoglu V
Fetal Pediatr Pathol; 2010; 29(3):127-32. PubMed ID: 20450265
[TBL] [Abstract][Full Text] [Related]
18. Serum alpha-fetoprotein subfractions in patients with primary hepatoma or hepatic metastasis of gastric cancer.
Ishiguro T; Sugitachi I; Sakaguchi H; Itani S
Cancer; 1985 Jan; 55(1):156-9. PubMed ID: 2578079
[TBL] [Abstract][Full Text] [Related]
19. A teratoid Wilms' tumor with raised serum alpha-fetoprotein level.
Ashworth MT; Pizer BL; Oakhill A; Spicer RD; Berry PJ
Pediatr Pathol Lab Med; 1996; 16(5):853-9. PubMed ID: 9025883
[TBL] [Abstract][Full Text] [Related]
20. [Expression profiles and differential diagnostic value of serum Golgi protein-73 in patients with liver cirrhosis and primary hepatic carcinoma].
Yang Y; Xiao L; Mao R; Zhang H; Wen H; Zhao HR; He FP; Zhang YF; Bao YX
Zhonghua Gan Zang Bing Za Zhi; 2012 Dec; 20(12):920-4. PubMed ID: 23522254
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
